pling and Laboratory analysis: FWD, PAS, STS, HKS, ITK, ATY and JS.

Statistical analysis and interpretation of data: FWD, PAS, STS, ATY, TRC and AKO.

Drafting of the manuscript: FWD, PAS, STS, ATY, BMN, TRC, HKS, ITK, AKO, BVJTEB and JS.

Critical revision of the manuscript for important intellectual content: FWD, ATY, BMN and JS.

Administrative, technical, and material support: BMN, ATY, FWD and JS.

Study supervision: FWD and JS.

Manuscript Approval: All authors have read and approved the manuscript.

NOTES

#These authors contributed equally to this article.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1] OMS (2017) VIH/sida aide memoire.
[2] ONUSIDA (2018) Dernières statistiques sur l’état de l’épidémie de sida.
http://www.unaids.org/fr/resources/fact-sheet
[3] Brites, C., et al. (2016) Extensive Variation in Drug-Resistance Mutational Profile of Brazilian Patients Failing Antiretroviral Therapy in Five Large Brazilian Cities. The Brazilian Journal of Infectious Diseases, 20, 323-329.
https://doi.org/10.1016/j.bjid.2016.03.010
[4] Ndahimana, J., et al. (2016) Drug Resistance Mutations after the First 12 Months on Antiretroviral Therapy and Determinants of Virological Failure in Rwanda. Tropical Medicine & International Health, 21, 928-935.
https://doi.org/10.1111/tmi.12717
[5] Zhou, Y., et al. (2016) Prevalence of HIV Antiretroviral Drug Resistance and Its Impacts on HIV-1 Virological Failures in Jiangsu, China: A Cross-Sectional Study. BioMed Research International, 2016, Article ID: 1752437.
https://doi.org/10.1155/2016/1752437
[6] Compaore, T.R., et al. (2016) APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso. PLoS ONE, 11, e0146386.
https://doi.org/10.1371/journal.pone.0146386
[7] Kagone, T.S., et al. (2014) A Variant of DC-SIGN Gene Promoter Associated with Resistance to HIV-1 in Serodiscordant Couples in Burkina Faso. Asian Pacific Journal of Tropical Medicine, 7, S93-S96.
https://doi.org/10.1016/S1995-7645(14)60211-X
[8] Strange, R.C., Spiteri, M.A., Ramachandran, S. and Fryer, A.A. (2001) Glutathione- S-Transferase Family of Enzymes. Mutation Research, 482, 21-26.
https://doi.org/10.1016/S0027-5107(01)00206-8
[9] Board, P.G., et al. (2000) Identification, Characterization, and Crystal Structure of the Omega Class Glutathione Transferases. The Journal of Biological Chemistry, 275, 24798-24806.
https://doi.org/10.1074/jbc.M001706200
[10] Mannervik, B. and Danielson, U.H. (1988) Glutathione Transferases—Structure and Catalytic Activity. Critical Reviews in Biochemistry, 23, 283-337.
https://doi.org/10.3109/10409238809088226
[11] Watson, R.W., et al. (1997) Augmented Intracellular Glutathione Inhibits Fas-Triggered Apoptosis of Activated Human Neutrophils. Blood, 89, 4175-4181.
https://doi.org/10.1182/blood.V89.11.4175
[12] Zhao, L., et al. (2000) Molecular Modeling and in Vitro Activity of an HIV-1-Encoded Glutathione Peroxidase. Proceedings of the National Academy of Sciences of the United States of America, 97, 6356-6361.
https://doi.org/10.1073/pnas.97.12.6356
[13] DeMarini, D.M., et al. (1997) Glutathione S-Transferase-Mediated Induction of GC→AT Transitions by Halomethanes in Salmonella. Environmental and Molecular Mutagenesis, 30, 440-447.
https://doi.org/10.1002/(SICI)1098-2280(1997)30:4<440::AID-EM9>3.0.CO;2-M
[14] Pemble, S., et al. (1994) Human Glutathione S-Transferase Theta (GSTT1): cDNA Cloning and the Characterization of a Genetic Polymorphism. Biochemical Journal, 300, 271-276.
https://doi.org/10.1042/bj3000271
[15] Soto-Quintana, O., et al. (2015) Association of the GSTM1 Null Polymorphism with Breast Cancer in a Mexican Population. Genetics and Molecular Research, 14, 13066- 13075.
https://doi.org/10.4238/2015.October.26.2
[16] Khabaz, M.N., et al. (2016) GSTM1 Gene Polymorphism and the Risk of Colorectal Cancer in a Saudi Arabian Population. Genetics and Molecular Research, 15, 1-9.
https://doi.org/10.4238/gmr.15017551
[17] Kirk, G.D., et al. (2005) Hepatocellular Carcinoma and Polymorphisms in Carcinogen-Metabolizing and DNA Repair Enzymes in a Population with Aflatoxin Exposure and Hepatitis B Virus Endemicity. Cancer Epidemiology, Biomarkers & Prevention, 14, 373-379.
https://doi.org/10.1158/1055-9965.EPI-04-0161
[18] Lu, L., et al. (2014) Association of Glutathione S-Transferase M1/T1 Polymorphisms with Susceptibility to Vitiligo. Gene, 535, 12-16.
https://doi.org/10.1016/j.gene.2013.11.024
[19] Nomani, H., et al. (2011) The Association between GSTT1, M1, and P1 Polymorphisms with Coronary Artery Disease in Western Iran. Molecular and Cellular Biochemistry, 354, 181-187.
https://doi.org/10.1007/s11010-011-0817-2
[20] Sui, Y., et al. (2011) Association of Glutathione S-Transferase M1 and T1 Null Polymorphisms with the Development of Cervical Lesions: A Meta-Analysis. European Journal of Obstetrics and Gynecology, 159, 443-448.
https://doi.org/10.1016/j.ejogrb.2011.09.012
[21] Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A Simple Salting out Procedure for Extracting DNA from Human Nucleated Cells. Nucleic Acids Research, 16, 1215.
https://doi.org/10.1093/nar/16.3.1215
[22] Chen, C.L., et al. (1997) Higher Frequency of Glutathione S-Transferase Deletions in Black Children with Acute Lymphoblastic Leukemia. Blood, 89, 1701-1707.
https://doi.org/10.1182/blood.V89.5.1701
[23] CDC (2013) Diagnoses of HIV Infection in the United States and Dependent Areas. HIV Surveillance Report, Volume 23.
[24] WHO (2016) Consolidated Guidelines on the Use of Antitrtroviral Drugs for Treating and Preventing HIV Infection Recommendations for a Public Health Approach.
https://www.who.int/hiv/pub/arv/summary-recommendations.pdf
[25] WHO (2019) Inégalités entre les sexes et VIH/sida.
https://www.who.int/gender/hiv_aids/fr/
[26] Deeks, S.G. and Phillips, A.N. (2009) HIV Infection, Antiretroviral Treatment, Ageing, and Non-AIDS Related Morbidity. BMJ, 338, a3172.
https://doi.org/10.1136/bmj.a3172
[27] Piacentini, S., et al. (2011) GSTT1 and GSTM1 Gene Polymorphisms in European and African Populations. Molecular Biology Reports, 38, 1225-1230.
https://doi.org/10.1007/s11033-010-0221-0
[28] Palma-Cano, L.E., et al. (2017) GSTT1 and GSTM1 Null Variants in Mestizo and Amerindian Populations from Northwestern Mexico and a Literature Review. Genetics and Molecular Biology, 40, 727-735.
https://doi.org/10.1590/1678-4685-gmb-2016-0142
[29] Dandara, C., et al. (2002) Genetic Polymorphism of Cytochrome P450 1A1 (Cyp1A1) and Glutathione Transferases (M1, T1 and P1) among Africans. Clinical Chemistry and Laboratory Medicine, 40, 952-957.
https://doi.org/10.1515/CCLM.2002.167
[30] Santovito, A., Burgarello, C., Cervella, P. and Delpero, M. (2010) Polymorphisms of Cytochrome P450 1A1, Glutathione s-Transferases M1 and T1 Genes in Ouangolodougou (Northern Ivory Coast). Genetics and Molecular Biology, 33, 434-437.
https://doi.org/10.1590/S1415-47572010005000059
[31] Hamdy, S.I., et al. (2003) Genotype and Allele Frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian Population. British Journal of Clinical Pharmacology, 55, 560-569.
https://doi.org/10.1046/j.1365-2125.2003.01786.x
[32] Ouerhani, S., et al. (2006) The Role of Glutathione Transferases M1 and T1 in Individual Susceptibility to Bladder Cancer in a Tunisian Population. Annals of Human Biology, 33, 529-535.
https://doi.org/10.1080/03014460600907517
[33] Kassogue, Y., et al. (2014) Effect of Interaction of Glutathione S-Transferases (T1 and M1) on the Hematologic and Cytogenetic Responses in Chronic Myeloid Leukemia Patients Treated with Imatinib. Medical Oncology, 31, 47.
https://doi.org/10.1007/s12032-014-0047-z
[34] Wild, C.P., et al. (2000) Environmental and Genetic Determinants of Aflatoxin-Albumin Adducts in the Gambia. International Journal of Cancer, 86, 1-7.
https://doi.org/10.1002/(SICI)1097-0215(20000401)86:1<1::AID-IJC1>3.0.CO;2-I
[35] Buchard, A., Sanchez, J.J., Dalhoff, K. and Morling, N. (2007) Multiplex PCR Detection of GSTM1, GSTT1, and GSTP1 Gene Variants: Simultaneously Detecting GSTM1 and GSTT1 Gene Copy Number and the Allelic Status of the GSTP1 Ile105Val Genetic Variant. The Journal of Molecular Diagnostics, 9, 612-617.
https://doi.org/10.2353/jmoldx.2007.070030
[36] Singh, H.O., et al. (2017) Impact of GSTM1, GSTT1 and GSTP1 Gene Polymorphism and Risk of ARV-Associated Hepatotoxicity in HIV-Infected Individuals and Its Modulation. The Pharmacogenomics Journal, 17, 53-60.
https://doi.org/10.1038/tpj.2015.88
[37] Ciccacci, C., et al. (2017) Impact of Glutathione Transferases Genes Polymorphisms in Nevirapine Adverse Reactions: A Possible Role for GSTM1 in SJS/TEN Susceptibility. European Journal of Clinical Pharmacology, 73, 1253-1259.
https://doi.org/10.1007/s00228-017-2295-2
[38] Kuleape, J.A., Tagoe, E.A., Puplampu, P., Bonney, E.Y. and Quaye, O. (2018) Homozygous Deletion of Both GSTM1 and GSTT1 Genes Is Associated with Higher CD4+ T Cell Counts in Ghanaian HIV Patients. PLoS ONE, 13, e0195954.
https://doi.org/10.1371/journal.pone.0195954
[39] Parsons, M., et al. (2013) Effect of GSTM1-Polymorphism on Disease Progression and Oxidative Stress in HIV Infection: Modulation by HIV/HCV Co-Infection and Alcohol Consumption. Journal of AIDS and Clinical Research, 4, Article ID: 10002337.
[40] Ketterer, B. (2001) A Bird’s Eye View of the Glutathione Transferase Field. Chemico-Biological Interactions, 138, 27-42.
https://doi.org/10.1016/S0009-2797(01)00277-0
[41] Economopoulos, K.P. and Sergentanis, T.N. (2010) GSTM1, GSTT1, GSTP1, GSTA1 and Colorectal Cancer Risk: A Comprehensive Meta-Analysis. European Journal of Cancer, 46, 1617-1631.
https://doi.org/10.1016/j.ejca.2010.02.009
[42] Liu, D., Liu, Y., Ran, L.M., Shang, H.P. and Li, D.T. (2013) GSTT1 and GSTM1 Polymorphisms and Prostate Cancer Risk in Asians: A Systematic Review and Meta-Analysis. Tumor Biology, 34, 2539-2544.
https://doi.org/10.1007/s13277-013-0778-z
[43] Wang, D., Wang, B., Zhai, J.X., Liu, D.W. and Sun, G.G. (2011) Glutathione S-Transferase M1 and T1 Polymorphisms and Cervical Cancer Risk: A Meta-Analysis. Neoplasma, 58, 352-359.
https://doi.org/10.4149/neo_2011_04_352
[44] Gil, L., et al. (2003) Contribution to Characterization of Oxidative Stress in HIV/AIDS Patients. Pharmacological Research, 47, 217-224.
https://doi.org/10.1016/S1043-6618(02)00320-1
[45] Morris, D., et al. (2012) Unveiling the Mechanisms for Decreased Glutathione in Individuals with HIV Infection. Clinical and Developmental Immunology, 2012, Article ID: 734125.
https://doi.org/10.1155/2012/734125
[46] Repetto, M., et al. (1996) Oxidative Stress in Blood of HIV Infected Patients. Clinica Chimica Acta, 255, 107-117.
https://doi.org/10.1016/0009-8981(96)06394-2

  
comments powered by Disqus
JBM Subscription
E-Mail Alert
JBM Most popular papers
Publication Ethics & OA Statement
JBM News
Frequently Asked Questions
Recommend to Peers
Recommend to Library
Contact Us

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.